PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
Abstract Ischaemic heart disease is the world’s leading cause of mortality. Survival rates from acute myocardial infarction (MI) have improved in recent years; however, this has led to an increase in the prevalence of heart failure (HF) due to chronic remodelling of the infarcted myocardium, for whi...
Guardado en:
Autores principales: | Nicholas Stafford, Min Zi, Florence Baudoin, Tamer M. A. Mohamed, Sukhpal Prehar, Daria De Giorgio, Elizabeth J. Cartwright, Roberto Latini, Ludwig Neyses, Delvac Oceandy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4179615b5a6949a8af26a24a91ac9b86 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
por: Tamer M. A. Mohamed, et al.
Publicado: (2016) -
Application of machine learning to predict the occurrence of arrhythmia after acute myocardial infarction
por: Suhuai Wang, et al.
Publicado: (2021) -
Matrix metalloprotease 9 and remodeling after myocardial infarction
por: M. G. Shurygin, et al.
Publicado: (2013) -
Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models
por: Hermenegild J. Arevalo, et al.
Publicado: (2016) -
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
por: Michał Węgiel, et al.
Publicado: (2021)